1,202 research outputs found
A simple clinical model for planning transfusion quantities in heart surgery
<p>Abstract</p> <p>Background</p> <p>Patients undergoing heart surgery continue to be the largest demand on blood transfusions. The need for transfusion is based on the risk of complications due to poor cell oxygenation, however large transfusions are associated with increased morbidity and risk of mortality in heart surgery patients. The aim of this study was to identify preoperative and intraoperative risk factors for transfusion and create a reliable model for planning transfusion quantities in heart surgery procedures.</p> <p>Methods</p> <p>We performed an observational study on 3315 consecutive patients who underwent cardiac surgery between January 2000 and December 2007. To estimate the number of packs of red blood cells (PRBC) transfused during heart surgery, we developed a multivariate regression model with discrete coefficients by selecting dummy variables as regressors in a stepwise manner. Model performance was assessed statistically by splitting cases into training and testing sets of the same size, and clinically by investigating the clinical course details of about one quarter of the patients in whom the difference between model estimates and actual number of PRBC transfused was higher than the root mean squared error.</p> <p>Results</p> <p>Ten preoperative and intraoperative dichotomous variables were entered in the model. Approximating the regression coefficients to the nearest half unit, each dummy regressor equal to one gave a number of half PRBC. The model assigned 4 units for kidney failure requiring preoperative dialysis, 2.5 units for cardiogenic shock, 2 units for minimum hematocrit at cardiopulmonary bypass less than or equal to 20%, 1.5 units for emergency operation, 1 unit for preoperative hematocrit less than or equal to 40%, cardiopulmonary bypass time greater than 130 minutes and type of surgery different from isolated artery bypass grafting, and 0.5 units for urgent operation, age over 70 years and systemic arterial hypertension.</p> <p>Conclusions</p> <p>The regression model proved reliable for quantitative planning of number of PRBC in patients undergoing heart surgery. Besides enabling more rational resource allocation of costly blood-conservation strategies and blood bank resources, the results indicated a strong association between some essential postoperative variables and differences between the model estimate and the actual number of packs transfused.</p
Allogeneic blood transfusion and prognosis following total hip replacement: a population-based follow up study
<p>Abstract</p> <p>Background</p> <p>Allogeneic red blood cell transfusion is frequently used in total hip replacement surgery (THR). However, data on the prognosis of transfused patients are sparse. In this study we compared the risk of complications following THR in transfused and non-transfused patients.</p> <p>Methods</p> <p>A population-based follow-up study was performed using data from medical databases in Denmark. We identified 28,087 primary THR procedures performed from 1999 to 2007, from which we computed a propensity score for red blood cell transfusion based on detailed data on patient-, procedure-, and hospital-related characteristics. We were able to match 2,254 transfused with 2,254 non-transfused THR patients using the propensity score.</p> <p>Results</p> <p>Of the 28,087 THR patients, 9,063 (32.3%) received at least one red blood cell transfusion within 8 days of surgery. Transfused patients had higher 90-day mortality compared with matched non-transfused patients: the adjusted OR was 2.2 (95% confidence interval (CI): 1.2-3.8). Blood transfusion was also associated with increased odds of pneumonia (OR 2.1; CI: 1.2-3.8), whereas the associations with cardiovascular or cerebrovascular events (OR 1.4; CI: 0.9-2.2) and venous thromboembolism (OR 1.2; CI: 0.7-2.1) did not reach statistical significance. The adjusted OR of reoperation due to infection was 0.6 (CI: 0.1-2.9).</p> <p>Conclusions</p> <p>Red blood cell transfusion was associated with an adverse prognosis following primary THR, in particular with increased odds of death and pneumonia. Although the odds estimates may partly reflect unmeasured bias due to blood loss, they indicate the need for careful assessment of the risk versus benefit of transfusion even in relation to routine THR procedures.</p
Theoretical survey of tidal-charged black holes at the LHC
We analyse a family of brane-world black holes which solve the effective
four-dimensional Einstein equations for a wide range of parameters related to
the unknown bulk/brane physics. We first constrain the parameters using known
experimental bounds and, for the allowed cases, perform a numerical analysis of
their time evolution, which includes accretion through the Earth. The study is
aimed at predicting the typical behavior one can expect if such black holes
were produced at the LHC. Most notably, we find that, under no circumstances,
would the black holes reach the (hazardous) regime of Bondi accretion.
Nonetheless, the possibility remains that black holes live long enough to
escape from the accelerator (and even from the Earth's gravitational field) and
result in missing energy from the detectors.Comment: RevTeX4, 12 pages, 4 figures, 5 tables, minor changes to match the
accepted version in JHE
Reducing the immediate availability of red blood cells in cardiac surgery, a single-centre experience
Socioeconomic Position, Not Race, Is Linked to Death After Cardiac Surgery
Background—Health disparities have been associated with the prevalence of cardiovascular disease. In cardiac surgery,
association has been found between race, sex, and poorer prognosis after surgery. However, there is a complex interplay
between race, sex, and socioeconomic position (SEP). In our investigation we sought to identify which of these was the
driver of risk-adjusted survival.
Methods and Results—From January 1, 1995, and December 30, 2005, 23 330 patients (15 156 white men, 6932 white
women, 678 black men, and 564 black women) underwent isolated coronary artery bypass grafting, valve, or combined
coronary artery bypass grafting and valve procedures. Median follow-up was 5.8 years (25th and 75th percentiles: 3 and
8.6 years). Effect of race, sex, and SEP on all-cause mortality was examined with 2-phase Cox model and generalized
propensity score technique. As expected, blacks and women had lower SEP as compared with whites and men for all
6 SEP indicators. Patients with lower SEP had more atherosclerotic disease burden, more comorbidity, and were more
symptomatic. Lower SEP was associated with a risk-adjusted dose-dependent reduction in survival after surgery (men,
P 0.0001; women, P 0.0079), but black race, once adjusted for SEP, was not.
Conclusions—Our large investigation demonstrates that disparities in SEP are present and significantly affect health
outcomes. Although race per se was not the driver for reduced survival, patients of low SEP were predominantly
represented by blacks and women. Socioeconomically disadvantaged patients had significantly higher risk-adjusted
mortality after surgery. Further investigation and targeted intervention should focus specifically on patients of low SEP,
their health behaviors, and secondary prevention efforts.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/79037/1/Koch_et_al.pd
Does blood transfusion harm cardiac surgery patients?
Over recent years there has been a substantial body of evidence demonstrating strong associations between transfusion and adverse outcomes, including myocardial, neurological and renal injury, in a range of clinical settings where transfusion is administered for reasons other than life-threatening bleeding. The strength of these associations across a range of clinical settings suggests that confounding and bias, the chief limitations of all observational studies, are unlikely to account for all of these observations. Given the wide range in transfusion rates in cardiac centres, with up to 100% of patients in some centres exposed to allogenic blood components, this evidence, albeit circumstantial, presents a strong argument for prospective randomised trials to attempt to determine, firstly, if transfusion causes adverse outcomes, and secondly, in which patient groups does the benefit of transfusion outweigh these risks? These issues are discussed in the context of an article published this month in BMC Medicine
Assessment of potential cardiotoxic side effects of mitoxantrone in patients with multiple sclerosis
Previous studies showed that mitoxantrone can reduce disability progression in patients with multiple sclerosis (MS). There is, however, concern that it may cause irreversible cardiomyopathy with reduced left ventricular (LV) ejection fraction (EF) and congestive heart failure. The aim of this prospective study was to investigate cardiac side effects of mitoxantrone by repetitive cardiac monitoring in MS patients. The treatment protocol called for ten courses of a combined mitoxantrone (10 mg/m(2) body surface) and methylprednisolone therapy. Before each course, a transthoracic echocardiogram was performed to determine the LV end-diastolic diameter, the end-systolic diameter and the fractional shortening; the LV-EF was calculated. Seventy-three patients participated (32 males; age 48 +/- 12 years, range 20-75 years; 25 with primary progressive, 47 with secondary progressive and 1 with relapsing-remitting MS) who received at least four courses of mitoxantrone. Three of the 73 patients were excluded during the study (2 patients discontinued therapy; 1 patient with a previous history of ischemic heart disease developed atrial fibrillation after the second course of mitoxantrone). The mean cumulative dose of mitoxantrone was 114.0 +/- 33.8 mg. The mean follow-up time was 23.4 months (range 10-57 months). So far, there has been no significant change in any of the determined parameters (end-diastolic diameter, end-systolic diameter, fractional shortening, EF) over time during all follow-up investigations. Mitoxantrone did not cause signs of congestive heart failure in any of the patients. Further cardiac monitoring is, however, needed to determine the safety of mitoxantrone after longer follow-up times and at higher cumulative doses. Copyright (C) 2005 S. Karger AG, Basel
F-Theorem without Supersymmetry
The conjectured F-theorem for three-dimensional field theories states that
the finite part of the free energy on S^3 decreases along RG trajectories and
is stationary at the fixed points. In previous work various successful tests of
this proposal were carried out for theories with {\cal N}=2 supersymmetry. In
this paper we perform more general tests that do not rely on supersymmetry. We
study perturbatively the RG flows produced by weakly relevant operators and
show that the free energy decreases monotonically. We also consider large N
field theories perturbed by relevant double trace operators, free massive field
theories, and some Chern-Simons gauge theories. In all cases the free energy in
the IR is smaller than in the UV, consistent with the F-theorem. We discuss
other odd-dimensional Euclidean theories on S^d and provide evidence that
(-1)^{(d-1)/2} \log |Z| decreases along RG flow; in the particular case d=1
this is the well-known g-theorem.Comment: 34 pages, 2 figures; v2 refs added, minor improvements; v3 refs
added, improved section 4.3; v4 minor improvement
Acute haemoabdomen associated with Angiostrongylus vasorum infection in a dog: a case report
A one-year-old intact female, Danish shorthaired pointer was referred to the emergency service with a history of acute collapse and pale mucous membranes after a month of reduced activity but with no other clinical signs. An ultrasound examination of the abdomen indicated the presence of a large amount of free fluid with no obvious cause such as neoplasia or splenic rupture. Fluid analysis had the macroscopic appearance of blood with no signs of infection or neoplasia. Multiple Angiostrongylus vasorum L1 larvae were revealed on a direct rectal faecal smear. The dog was treated with fenbendazole 25 mg/kg orally once daily for 20 days and given supportive treatment. The dog was stabilised on this treatment. Haemoabdomen is a clinical sign where surgical intervention is often considered an integral part of the diagnostic investigation (i.e., laparotomy) or treatment. Failing to make the diagnosis of canine angiostrongylosis before performing surgery may have a serious adverse affect on the outcome. Consequently, in areas where A. vasorum is enzootic, a Baermann test and a direct faecal smear should be included in the initial diagnostic investigation of all dogs presenting with bleeding disorders of unknown origin
Should red cell transfusion be individualized? Yes
SCOPUS: ed.jinfo:eu-repo/semantics/publishe
- …